Birgit Gruenberger

2.7k total citations
58 papers, 1.6k citations indexed

About

Birgit Gruenberger is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Birgit Gruenberger has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 30 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Birgit Gruenberger's work include Colorectal Cancer Treatments and Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Cancer Treatment and Pharmacology (17 papers). Birgit Gruenberger is often cited by papers focused on Colorectal Cancer Treatments and Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Cancer Treatment and Pharmacology (17 papers). Birgit Gruenberger collaborates with scholars based in Austria, Germany and Netherlands. Birgit Gruenberger's co-authors include Thomas Gruenberger, Dietmar Tamandl, Beata Herberger, Markus Klinger, Klaus Kaczirek, Fritz Wrba, Harald Puhalla, Stefan Hacker, Patrick Starlinger and Christine Brostjan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Birgit Gruenberger

56 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Birgit Gruenberger 1.0k 703 645 475 193 58 1.6k
Maria Chiara Tronconi 1.1k 1.0× 277 0.4× 704 1.1× 370 0.8× 147 0.8× 44 1.4k
Christoph Benckert 626 0.6× 507 0.7× 728 1.1× 457 1.0× 247 1.3× 45 1.4k
Armin Thelen 876 0.8× 563 0.8× 1.2k 1.8× 740 1.6× 171 0.9× 45 1.8k
Lehua Shi 819 0.8× 557 0.8× 863 1.3× 664 1.4× 282 1.5× 40 1.8k
Mashaal Dhir 690 0.7× 394 0.6× 627 1.0× 346 0.7× 358 1.9× 54 1.5k
Lucjan Wyrwicz 919 0.9× 385 0.5× 355 0.6× 683 1.4× 112 0.6× 41 1.4k
Kenzo Yasui 1.1k 1.0× 374 0.5× 1.1k 1.7× 1.1k 2.3× 116 0.6× 74 2.1k
Zhenlin Yan 697 0.7× 714 1.0× 954 1.5× 678 1.4× 237 1.2× 36 1.9k
Lie Zheng 387 0.4× 579 0.8× 387 0.6× 254 0.5× 157 0.8× 70 1.3k
Keun Soo Ahn 481 0.5× 499 0.7× 660 1.0× 326 0.7× 117 0.6× 66 1.2k

Countries citing papers authored by Birgit Gruenberger

Since Specialization
Citations

This map shows the geographic impact of Birgit Gruenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Gruenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Gruenberger more than expected).

Fields of papers citing papers by Birgit Gruenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Gruenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Gruenberger. The network helps show where Birgit Gruenberger may publish in the future.

Co-authorship network of co-authors of Birgit Gruenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Gruenberger. A scholar is included among the top collaborators of Birgit Gruenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Gruenberger. Birgit Gruenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santol, Jonas, Birgit Gruenberger, A. Lenauer, et al.. (2024). Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers. 16(5). 857–857. 1 indexed citations
2.
Taghizadeh, Hossein, Angela Djanani, Wolfgang Eisterer, et al.. (2023). Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement. Frontiers in Oncology. 13. 1225154–1225154. 2 indexed citations
3.
Wöll, Ewald, Josef Thaler, Felix Keil, et al.. (2017). Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/ Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients – AGMT_GASTRIC-3. Anticancer Research. 37(10). 5553–5558. 9 indexed citations
4.
Gruenberger, Thomas, Geerard L. Beets, Jean‐Luc Van Laethem, et al.. (2016). Treatment sequence of synchronously (liver) metastasized colon cancer. Digestive and Liver Disease. 48(10). 1119–1123. 14 indexed citations
5.
Schauer, Dominic, Patrick Starlinger, Thomas Maier, et al.. (2016). Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. OncoImmunology. 5(6). e1160185–e1160185. 13 indexed citations
6.
Haegele, Stefanie, David Pereyra, Alice Assinger, et al.. (2015). Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction. PLoS ONE. 10(1). e0116985–e0116985. 11 indexed citations
7.
Stremitzer, Stefan, Judith Stift, Alexandra Gráf, et al.. (2014). CEA Change After Neoadjuvant Chemotherapy Including Bevacizumab and Clinical Outcome in Patients Undergoing Liver Resection for Colorectal Liver Metastases. Annals of Surgical Oncology. 22(4). 1315–1323. 16 indexed citations
8.
Starlinger, Patrick, Alice Assinger, Stefanie Haegele, et al.. (2013). Evidence for Serotonin as a Relevant Inducer of Liver Regeneration After Liver Resection in Humans. Hepatology. 60(1). 257–266. 72 indexed citations
9.
Starlinger, Patrick, Dominic Schauer, T. Maier, et al.. (2012). Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation. British Journal of Cancer. 107(6). 961–966. 20 indexed citations
10.
Czejka, Martin, et al.. (2010). Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen. Cancer Chemotherapy and Pharmacology. 67(3). 613–619. 2 indexed citations
11.
Starlinger, Patrick, Herwig P. Moll, Alice Assinger, et al.. (2010). Thrombospondin‐1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. Journal of Thrombosis and Haemostasis. 8(8). 1809–1819. 49 indexed citations
12.
Tamandl, Dietmar, Markus Klinger, Beata Herberger, et al.. (2010). Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 18(2). 421–430. 109 indexed citations
13.
Tamandl, Dietmar, Birgit Gruenberger, Markus Klinger, et al.. (2010). Liver Resection Remains a Safe Procedure After Neoadjuvant Chemotherapy Including Bevacizumab. Annals of Surgery. 252(1). 124–130. 36 indexed citations
14.
Klinger, Markus, Stefan Hacker, Beata Herberger, et al.. (2009). Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. European Journal of Surgical Oncology. 35(5). 515–520. 123 indexed citations
15.
Brostjan, Christine, et al.. (2008). Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The Perioperative Angiogenic Balance Is Sensitive to Systemic Thrombospondin-1 Levels. Clinical Cancer Research. 14(7). 2065–2074. 25 indexed citations
16.
Schmid‐Kubista, Katharina E., et al.. (2008). Systemic Bevacizumab Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study). Investigative Ophthalmology & Visual Science. 49(13). 304–304. 2 indexed citations
17.
Gruenberger, Birgit, et al.. (2008). Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer. 8(1). 120–120. 90 indexed citations
18.
Klinger, Markus, et al.. (2008). Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. European Journal of Surgical Oncology. 34(11). 1231–1236. 64 indexed citations
19.
Tamandl, Dietmar, Beata Herberger, Birgit Gruenberger, et al.. (2008). Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 15(10). 2787–2794. 120 indexed citations
20.
Gruenberger, Birgit, Marlene Troch, W. Hauff, et al.. (2008). Assessment of the role of hepatitis C,Helicobacter pyloriand autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients. Acta Oncologica. 47(3). 355–359. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Chiara Tronconi Breakdown of academic impact, for papers by Christoph Benckert Breakdown of academic impact, for papers by Armin Thelen Breakdown of academic impact, for papers by Lehua Shi Breakdown of academic impact, for papers by Mashaal Dhir Breakdown of academic impact, for papers by Lucjan Wyrwicz Breakdown of academic impact, for papers by Kenzo Yasui Breakdown of academic impact, for papers by Zhenlin Yan Breakdown of academic impact, for papers by Lie Zheng Breakdown of academic impact, for papers by Keun Soo Ahn
Rankless by CCL
2026